A multicenter study darunavir and/or etravirine for HIV drug resistance patterns among highly treatment experienced children, adolescents and young adults in sub-Saharan Africa
Latest Information Update: 03 Sep 2021
At a glance
- Drugs Darunavir (Primary) ; Etravirine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 03 Sep 2021 New trial record
- 21 Jul 2021 Results presented at the 11th International AIDS Society Conference on HIV Science.